Competitive intelligence
Side-by-side comparison
Up to six companies on the same rows. Empty cells say what is missing rather than hiding it.
4 of 6 columns
Comparison
| Attribute | LifeCyte Innovations, Inc.5.8remove | Ratio Therapeutics, Inc.5.8remove | PLEOPHARMA, INC.5.5remove | Immunophotonics, Inc.5.5remove |
|---|---|---|---|---|
| Signal scores | ||||
| Radar composite | 5.8 | 5.8 | 5.5 | 5.5 |
| IPO signal score | 11.6 | 11.6 | 11.0 | 10.9 |
| Tokenization signal score | 0.0 | 0.0 | 0.0 | 0.0 |
| On-chain readiness | 0.0 | 0.0 | 0.0 | 0.0 |
| Momentum | STABLE+3.0 | STABLE0.0 | STABLE+0.2 | STABLE+7.9 |
| Company | ||||
| Stage | private | private | private | private |
| Sector | Health Care | Health Care | Health Care | Health Care |
| Headquarters | GREENSBORO, United States | BOSTON, United States | PHOENIXVILLE, United States | ST. LOUIS, United States |
| Founded | 2024 | not on record | not on record | not on record |
| Employees | not on record | not on record | not on record | not on record |
| Capital | ||||
| Latest valuation | not on record | not on record | not on record | not on record |
| Total funding | $1M | $70M | $6M | $10M |
| Latest round | Private Placement $1M | Private Placement $70M | Private Placement $6M | Private Placement $10M |
| Investors on record | 0 | 0 | 0 | 0 |
| Evidence | ||||
| Institutional relationships | 0 | 0 | 0 | 0 |
| Active signals | 1 | 1 | 2 | 1 |
| Confidence | 53% | 53% | 55% | 53% |
IPO Radar is a research and intelligence tool. Scores are signal scores derived from public evidence — they are not calibrated probabilities and not investment advice. FACT, INFERENCE and PREDICTION are kept separate, and every event links to its source.